Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma Research Letter
| Authors: | Lee, H. C.; Raje, N. S.; Landgren, O.; Upreti, V. V.; Wang, J.; Avilion, A. A.; Hu, X.; Rasmussen, E.; Ngarmchamnanrith, G.; Fujii, H.; Spencer, A. |
| Title: | Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma |
| Keywords: | treatment response; unclassified drug; drug tolerability; fatigue; drug efficacy; drug safety; side effect; antineoplastic agent; multiple myeloma; bayes theorem; anemia; nausea; thrombocytopenia; myalgia; incidence; body weight; minimal residual disease; informed consent; diplopia; dry eye; disease exacerbation; visual impairment; blurred vision; phase 1 clinical trial (topic); musculoskeletal pain; conjunctival hemorrhage; ocular pruritus; vitreous hemorrhage; human; priority journal; article; antibody drug conjugate; amg 224 |
| Journal Title: | Leukemia |
| Volume: | 35 |
| Issue: | 1 |
| ISSN: | 0887-6924 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2021-01-01 |
| Start Page: | 255 |
| End Page: | 258 |
| Language: | English |
| DOI: | 10.1038/s41375-020-0834-9 |
| PUBMED: | 32317775 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 February 2021 -- Source: Scopus |
